PMC:7692688 / 12166-12686 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue	tao:has_database_id
260	66-74	Gene	denotes	SERPINA1	Gene:5265
261	75-94	Gene	denotes	alpha-1 antitrypsin	Gene:5265
262	200-219	Gene	denotes	alpha-1 antitrypsin	Gene:5265
263	261-271	Species	denotes	SARS-CoV-2	Tax:2697049
264	303-313	Species	denotes	SARS-CoV-2	Tax:2697049
265	323-333	Species	denotes	SARS-CoV-2	Tax:2697049
266	344-354	Species	denotes	SARS-CoV-2	Tax:2697049
267	367-377	Species	denotes	SARS-CoV-2	Tax:2697049
268	387-397	Species	denotes	SARS-CoV-2	Tax:2697049
269	422-430	Species	denotes	patients	Tax:9606
270	465-473	Species	denotes	SARS-CoV	Tax:694009
271	507-514	Species	denotes	patient	Tax:9606
272	21-31	Species	denotes	SARS-CoV-2	Tax:2697049
273	220-230	Disease	denotes	deficiency	MESH:D007153

Id	Subject	Object	Predicate	Lexical cue
T109	0-366	Sentence	denotes	We compared the anti-SARS-CoV-2 activity of aprotinin [15,26] and SERPINA1/alpha-1 antitrypsin, an endogenous protease inhibitor that is available as a pharmaceutical preparation for the treatment of alpha-1 antitrypsin deficiency [27], against three different SARS-CoV-2 isolates from two lineages (L: SARS-CoV-2/FFM1 and SARS-CoV-2/FFM2; GR: SARS-CoV-2/FFM6) [18].
T110	367-520	Sentence	denotes	SARS-CoV-2/FFM1 and SARS-CoV-2/FFM2 were isolated from patients in Hubei province in China, while SARS-CoV/FFM6 was derived from an Italian patient [18].